Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta2-agonist Effects on Muscle and Performance
NCT03565302Unknown
- Start
- Jun 2018
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of formoterol and terbutaline (3 arms). Primary endpoint: Proteome enrichment at 6 weeks. Status: unknown.
02
Drugs
formoterolterbutaline
Beyond the preview
Go deeper on NCT03565302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03565302.